Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03879694
Title Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute

pulmonary neuroendocrine tumor

gastrointestinal neuroendocrine tumor

pancreatic endocrine carcinoma


Octreotide + Sargramostim + SurVaxM

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.